Jay D. Kranzler, CEO at CYPRESS BIOSCIENCE INC (CYPB), sold 75,000 shares at $8.70 ($653K) on 2009-07-06, disclosed to the SEC on 2009-07-08.
Scheduled sale ($652k) by CEO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| CYPB | SELL | 2010-12-29 | $162K | — | Filing → |
| CYPB | SELL | 2010-12-29 | $983K | — | Filing → |
| CYPB | SELL | 2009-08-04 | $652K | — | Filing → |